ListedPVA QPPV.com application

ELIDEL / squamous cell carcinoma

United States · event evidence

squamous cell carcinoma

Under review

Hematology/Oncology; reported in patients using ELIDEL Cream. The label states that frequency cannot always be reliably estimated or a causal relationship to drug exposure established.

Source evidence

The following adverse reactions have been reported in patients using ELIDEL Cream. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
squamous cell carcinoma

Return to label evidence explorer

Search products

Search by brand, active ingredient, INN or recorded alias.